We are live on ! Find out more
KLCM

KG&L Capital Management Portfolio holdings

AUM $168M
1-Year Est. Return 33.42%
This Fund
S&P 500
This Quarter Est. Return
+3.03%
1 Year Est. Return
+33.42%
3 Year Est. Return
+84.25%
5 Year Est. Return
+94.64%
10 Year Est. Return
AUM
$289M
AUM Growth
+$37.3M
Cap. Flow
+$30.1M
Cap. Flow %
10.41%
Top 10 Hldgs %
38.12%
Holding
197
New
24
Increased
84
Reduced
72
Closed
15

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$1.39M
2
BG icon
Bunge Global
BG
+$879K
3
RTX icon
RTX Corp
RTX
+$666K
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$581K
5
BAC icon
Bank of America
BAC
+$421K

Sector Composition

Rank Sector Weight
1 Technology 19.49%
2 Financials 13.23%
3 Consumer Staples 9.34%
4 Consumer Discretionary 7.98%
5 Healthcare 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AI icon
126
C3.ai
AI
$1.59B
$462K 0.16%
15,948
-9,437
-37% -$242K
MCO icon
127
Moody's
MCO
$82.7B
$461K 0.16%
1,096
+140
+15% +$55.7K
DELL icon
128
Dell
DELL
$293B
$451K 0.16%
+3,272
New +$439K
LMT icon
129
Lockheed Martin
LMT
$136B
$451K 0.16%
965
-28
-3% -$12.9K
NEE icon
130
NextEra Energy
NEE
$177B
$448K 0.16%
6,327
-4,695
-43% -$333K
GSK icon
131
GSK
GSK
$106B
$444K 0.15%
11,581
-33,002
-74% -$1.39M
KRO icon
132
KRONOS Worldwide
KRO
$989M
$433K 0.15%
35,158
-20,500
-37% -$259K
SO icon
133
Southern Company
SO
$107B
$424K 0.15%
5,487
-1,769
-24% -$134K
DVN icon
134
Devon Energy
DVN
$47.3B
$423K 0.15%
8,916
-1,285
-13% -$63.9K
GLD icon
135
SPDR Gold Trust
GLD
$142B
$421K 0.15%
1,960
-245
-11% -$53K
RTX icon
136
RTX Corp
RTX
$301B
$419K 0.15%
4,175
-6,438
-61% -$666K
VWO icon
137
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$418K 0.14%
9,561
+1,190
+14% +$51.3K
DDOG icon
138
Datadog
DDOG
$84B
$415K 0.14%
+3,200
New +$387K
IEF icon
139
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
$414K 0.14%
+4,420
New +$411K
HUM icon
140
Humana
HUM
$46.2B
$395K 0.14%
1,058
-259
-20% -$87.4K
NKE icon
141
Nike
NKE
$61.9B
$381K 0.13%
5,054
+1,302
+35% +$121K
NOC icon
142
Northrop Grumman
NOC
$81.2B
$375K 0.13%
+861
New +$393K
SMH icon
143
VanEck Semiconductor ETF
SMH
$71.8B
$375K 0.13%
+1,439
New +$337K
COF icon
144
Capital One
COF
$134B
$370K 0.13%
2,670
+562
+27% +$78.8K
NEM icon
145
Newmont
NEM
$119B
$366K 0.13%
8,751
-5,830
-40% -$238K
DFS
146
DELISTED
Discover Financial Services
DFS
$358K 0.12%
2,737
+525
+24% +$65.4K
PGR icon
147
Progressive
PGR
$125B
$351K 0.12%
+1,692
New +$354K
FTNT icon
148
Fortinet
FTNT
$117B
$339K 0.12%
+5,625
New +$350K
ABBV icon
149
AbbVie
ABBV
$435B
$339K 0.12%
1,974
-456
-19% -$75.5K
MDLZ icon
150
Mondelez International
MDLZ
$79.9B
$330K 0.11%
5,050
+2,153
+74% +$148K

Similar funds

KG&L Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, KG&L Capital Management held 197 positions worth $289M, up 15% from $252M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

KG&L Capital Management deployed $30.1M of net new capital in Q2 2024, opening 24 new positions and adding to 84 existing holdings. Its largest new stake was Dimensional US Core Equity 2 ETF: 355,575 shares worth $11.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was GSK, an estimated $1.39M trimmed.

  • KG&L Capital Management's largest Q2 2024 buy was Dimensional US Core Equity 2 ETF: 355,575 shares worth $11.5M.
  • KG&L Capital Management added most to F/m US Treasury 3 Month Bill Fund in Q2 2024, an estimated $1.4M increase.
  • KG&L Capital Management's biggest Q2 2024 reduction was GSK, cutting an estimated $1.39M.
  • KG&L Capital Management fully exited Bunge Global in Q2 2024, selling an estimated $879K.
  • KG&L Capital Management's ten largest holdings make up 38% of its $289M portfolio in Q2 2024.
  • KG&L Capital Management opened 24 new positions and closed 15 in Q2 2024.
  • KG&L Capital Management's portfolio value rose 15% quarter-over-quarter to $289M.

Based on KG&L Capital Management's 13F filing for Q2 2024, filed 23 Jul 2024.